WEISS MICHAEL S (CEO and President) sold 0.6% of their position (68.22K shares) of TG THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.28M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/7/2022ACC: 0001104659-22-002355
DirectorOfficer· CEO and President
Since Jun 2019
-723.83K
Net shares
Net seller
$1.28M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
56.39K acquired · 780.22K disposed
Non-Derivative Transactions6
COMMON STOCK
Direct
Shares
−3K
Price / share
—
Trade value
—
% of position
0.0%
12/15/2021
14.15M→14.15M
COMMON STOCK
Direct
Shares
−700K
Price / share
—
Trade value
—
% of position
4.9%
12/16/2021
14.15M→13.45M
COMMON STOCK
Direct
Shares
−9K
Price / share
—
Trade value
—
% of position
0.1%
12/16/2021
13.45M→13.44M
COMMON STOCK
Direct
Shares
+56.39K
Price / share
—
Trade value
—
% of position
0.4%
12/29/2021
13.44M→13.49M
COMMON STOCK
Direct
Shares
−37.55K
Price / share
$19.20
Trade value
$720.94K
% of position
0.3%
1/4/2022
13.49M→13.46M
COMMON STOCK
Direct
Shares
−30.67K
Price / share
$18.31
Trade value
$561.59K
% of position
0.3%
1/5/2022
11.02M→10.99M
Total
Net shares
−723.83K
Net value
-$1.28M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 12/15/2021 | G · Gift | −3K | — | — | 0.0% | 14.15M | 14.15M |
| COMMON STOCK Direct | 12/16/2021 | G · Gift | −700K | — | — | 4.9% | 14.15M | 13.45M |
| COMMON STOCK Direct | 12/16/2021 | G · Gift | −9K | — | — | 0.1% | 13.45M | 13.44M |
| COMMON STOCK Direct | 12/29/2021 | A · Award | +56.39K | — | — | 0.4% | 13.44M | 13.49M |
| COMMON STOCK Direct | 1/4/2022 | S · Sale | −37.55K | $19.20 | $720.94K | 0.3% | 13.49M | 13.46M |
| COMMON STOCK Direct | 1/5/2022 | S · Sale | −30.67K | $18.31 | $561.59K | 0.3% | 11.02M | 10.99M |
| Total | −723.83K | -$1.28M | ||||||
Derivative Transactions0
No derivative transactions reported